Back to Search Start Over

aTrial arrhythmias in inhEriTed aRrhythmIa Syndromes: results from the TETRIS study.

Authors :
Conte G
Bergonti M
Probst V
Morita H
Tfelt-Hansen J
Behr ER
Kengo K
Arbelo E
Crotti L
Sarquella-Brugada G
Wilde AAM
Calò L
Sarkozy A
de Asmundis C
Mellor G
Migliore F
Letsas K
Vicentini A
Levinstein M
Berne P
Chen SA
Veltmann C
Biernacka EK
Carvalho P
Kabawata M
Sojema K
Gonzalez MC
Tse G
Thollet A
Svane J
Caputo ML
Scrocco C
Kamakura T
Pardo LF
Lee S
Juárez CK
Martino A
Lo LW
Monaco C
Reyes-Quintero ÁE
Martini N
Oezkartal T
Klersy C
Brugada J
Schwartz PJ
Brugada P
Belhassen B
Auricchio A
Source :
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology [Europace] 2024 Nov 11. Date of Electronic Publication: 2024 Nov 11.
Publication Year :
2024
Publisher :
Ahead of Print

Abstract

Background: Little is known about the distribution and clinical course of patients with inherited arrhythmia syndrome (IAS) and concomitant atrial arrhythmias (AAs).<br />Aim: 1) to characterize the distribution of AAs in patients with IAS and 2) evaluate the long-term clinical course of these patients.<br />Methods: An international multicenter study was performed and involved 28 centers in 16 countries. Inclusion criteria were: 1) IAS and 2) ECG documentation of AAs. The primary endpoint was a composite of sudden cardiac death, sustained VAs or appropriate ICD interventions. Strokes, inappropriate ICD shocks due to AAs, and the occurrence of sinus node dysfunction were assessed.<br />Results: A total of 522 patients with IAS and AAs were included. Most patients were diagnosed with Brugada syndrome (n=355, 68%) and long-QT syndrome (n=93, 18%). The remaining patients (n=71, 14%) presented with short-QT syndrome, early repolarization syndrome (ERS), catecholaminergic polymorphic ventricular tachycardia (CPVT), progressive cardiac conduction diseases, or idiopathic ventricular fibrillation. Atrial fibrillation (AF) was the most prevalent AA (82%), followed by atrial flutter (9%) and atrial tachycardia (9%). AA was the first clinical manifestation of IAS in 52% of patients. More than one type of AAs was documented in 23% of patients. Nine patients (3%) experienced VA before the diagnosis of IAS, due the use of anti-arrhythmic medications taken for the AA. The incidence of the primary endpoint was 1.4% per year, with a twofold increase observed in patients who experienced their first AA before the age of 20 (OR 2.2, p=0.043). This was consistent across the different forms of IAS. Inappropriate ICD shock due to AAs were reported in 2.8% of patients, strokes in 4.4% and sinus node dysfunction in 9.6%.<br />Conclusions: Among patients with IAS and AAs, AA is the first clinical manifestation in about half of the cases, with more than one form of AAs present in one-fourth of the patients. The occurrence of AA earlier in life may be associated with a higher risk of ventricular arrhythmias. The occurrence of stroke and sinus node dysfunction is not-infrequently in this cohort.<br /> (© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.)

Details

Language :
English
ISSN :
1532-2092
Database :
MEDLINE
Journal :
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
Publication Type :
Academic Journal
Accession number :
39527076
Full Text :
https://doi.org/10.1093/europace/euae288